Outcomes of SLE in Immune-Mediated Thrombotic Thrombocytopenic Purpura
Thrombotic thrombocytopenic purpura related to SLE may not cause worse outcomes compared with primary immune-mediated TTP.
Thrombotic thrombocytopenic purpura related to SLE may not cause worse outcomes compared with primary immune-mediated TTP.
Patients with idiopathic thrombocytopenic purpura may have a higher risk of systemic lupus erythematosus and should be monitored for incidental lupus.
Low-dose aspirin was not associated with higher risk for fever recrudescence compared with high-dose aspirin in children with Kawasaki disease.
The guideline includes strategies to identify patients with nonmetastatic cancer who may be at a higher risk for osteoporotic fractures.